App-Quantinova.ai

Cardiac-specific Deletion of Protein Tyrosine Phosphatase 1B Exacerbates Pressure Overload-induced Hypertrophy and Heart Failure in Mice

Alexandre Bergeron - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertrophic cardiomyopathy

L-Tyrosine

Adherence to Cardiopulmonary Resuscitation Guidelines for the Entire Cardiac Arrest Duration on Patient Survival

Ian R Drennan - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

A randomized, double-blinded, placebo-controlled clinical trial of extended adjuvant endocrine therapy (tx) with letrozole (L) in postmenopausal women with hormone-receptor (+) breast cancer (BC) who have completed previous adjuvant tx with an aromatase inhibitor (AI): Results from NRG Oncology/NSABP B-42

EP Mamounas - San Antonio Breast Cancer Symposium (SABCS) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

Letrozole

Cpr Quality During Out- Of- Hospital Cardiac Arrest Transport

Cathy Zhan - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Antiarrhythmic Drugs for Shock Refractory Secondary Ventricular Fibrillation Following Initial Nonshockable Out-of-Hospital Cardiac Arrest: The Resuscitation Outcomes Consortium Amiodarone, Lidocaine or Placebo Study

Mohamud Daya - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

Amiodarone Hydrochloride

Impact of Mean Arterial Pressure on Clinical Outcomes in Comatose Survivors of Out-of-hospital Cardiac Arrest

Tyler E James - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Post-cardiac arrest syndrome

N/A

Advanced vs. Basic Life Support in the Treatment of Out-of-Hospital Cardiopulmonary Arrest in the Resuscitation Outcomes Consortium

Robert Schmicker - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Magnesium Lithospermate B Inhibits Blood Coagulation and Platelet Aggregation: Novel Mechanism of a Traditional Drug for Cardiovascular Diseases

Dan Zhang - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Deep vein thrombosis

Fibrinogen (IV)

A Multi-Statewide 5-Year Initiative to Improve Care for Out-of-Hospital Cardiac Arrest: Primary Results From the HeartRescue Project

Saket Girotra - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Resident Aortic Intimal Mononuclear Phagocytes (MNPs) in the Promotion of Atherosclerosis

Ki-Wook Kim - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

GM-CSF

Ventricular Functional Recovery and Neurologic Function After In-Hospital Cardiac Arrest in Pediatric Patients

Lisa Zhao - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Apabetalone (RVX-208) Has Anti-atherosclerotic, Anti-Thrombotic and Anti-Inflammatory Effects in Patients With Cardiovascular Disease (CVD)

Sylwia Wasiak - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

RVX-208

Microparticles Released From Various Cell lines are ABCA1 Dependent

Jan O Johansson - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Mucopolysaccharidosis 1S

cyclodextrin

Angiogenesis is Triggered by Nutrient Deprivation via Gcn2/atf4-dependent Regulation of Vegf and H2s Production

Teodelinda Mirabella - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

methionine

Predicting Survival From Pediatric Out-of-Hospital Cardiac Arrest

Kevin E Thorpe - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Discordance in Apolipoprotein B vs. non-HDL-C and the Cholesterol-Enriched Phenotype: Insights From the National Health and Nutrition Examination Survey (NHANES) 2011-2012

Mariana Lazo - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hypertension

N/A

Does Compliance With a Global Cpr Quality Benchmark Predict Survival From Out-Of-Hospital Cardiac Arrest?

Rob Schmicker - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Association Between Duration of Resuscitation and Favorable Outcome After Out-of-Hospital Cardiac Arrest: Implications for Prolonging Resuscitation

Brian E Grunau - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Improving Physical and Mental Health Through a Community-based, Multi-disciplinary Obesity Reduction Program Promoting Social Support and Adherence

Mark Lemstra - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

N/A

Exception to Consent in Pediatric Resuscitation Research: Exploring the Experiences of Substitute Decision Makers

Sonya de Laat - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Septic shock

N/A

Filters

28841 Abstracts